KRAS and cancer: For instance, RAF1 and SHOC2, which encode CRAF and SHOC2 respectively, have been shown to be important in KRAS-mutant cell lines, suggesting inhibition of CRAF and SHOC2 could be used in KRAS-mutant cancer.